Elite Pharmaceuticals, Inc. (ELTP) Net income 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$44.9MFY2026 · since FY2017: $3.8M → $44.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $44.9M | +1140.0% |
| FY2025 | -$4.3M | -121.5% |
| FY2024 | $20.1M | +464.6% |
| FY2023 | $3.6M | -60.0% |
| FY2022 | $8.9M | +74.9% |
| FY2021 | $5.1M | +327.1% |
| FY2020 | -$2.2M | +75.9% |
| FY2019 | -$9.3M | -152.6% |
| FY2018 | -$3.7M | -196.4% |
| FY2017 | $3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice